Clover Health Investments (CLOV) reports Q4 results; offers guidance

Clover Health Investments (NASDAQ: CLOV) reported Q4 Revenue for the quarter at $510.3 million versus the consensus estimate of $474.01 million.

GUIDANCE:

Clover Health Investments sees FY2024 Insurance revenue of $1.25-1.3 billion. Insurance MCR of 79% - 83%. Adjusted EBITDA (Non-GAAP) of ($20) million - $20 million

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79